# Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia

> **NCT00703820** · PHASE3 · COMPLETED · sponsor: **St. Jude Children's Research Hospital** · enrollment: 324 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **DRUG:** Cytarabine
- **DRUG:** Daunorubicin
- **DRUG:** Etoposide
- **DRUG:** Clofarabine
- **DEVICE:** CliniMACS

## Key facts

- **NCT ID:** NCT00703820
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-08-04
- **Primary completion:** 2017-03-30
- **Final completion:** 2020-08-14
- **Target enrollment:** 324 (ACTUAL)
- **Last updated:** 2021-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00703820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00703820, "Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT00703820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*